Enlaza Therapeutics Renews 37,000 SQFT in Torrey Pines as Class B Lab Vacancy Hits 2.1%

Enlaza Therapeutics, a venture-backed La Jolla biotech with a Vertex Pharmaceuticals collaboration potentially worth more than $2 billion, renewed 37,013 square feet of Class B lab space in Torrey Pines, choosing to hold its ground in a building class that is 2.1 percent vacant over chasing discounts in a Class A market that is nearly one-quarter empty.